PRECISION BIOSCIENCES INC — Director's Dealing 2022

Jun 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-06-07

Reporting Person: Kelly John Alexander (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-07	Common Stock	M	34090	—	Acquired	70279	Direct
2022-06-07	Common Stock	M	13638	—	Acquired	83917	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-07	Restricted Stock Units	$	M	34090	Disposed		Common Stock (34090)	Direct
2022-06-07	Restricted Stock Units	$	M	13638	Disposed		Common Stock (13638)	Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.

F2: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

F3: On June 7, 2021 the Reporting person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates

F4: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7,
2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.